Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.882863
Abstract: Objective 11β-Hydroxylase deficiency (11β-OHD) caused by mutations in the CYP11B1 gene is the second most common form of congenital adrenal hyperplasia. Both point mutations and genomic rearrangements of CYP11B1 are important causes of 11β-OHD. However,…
read more here.
Keywords:
cyp11b1;
chimeric cyp11b2;
gene;
cyp11b1 gene ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2022.1030551
Abstract: Objectives Ischemic stroke (IS) is the major cause of death and disability. While previous studies confirmed that CYP11B1 is closely associated with IS, the present study aimed to analyze the impact of CYP11B1 gene polymorphisms…
read more here.
Keywords:
gene polymorphisms;
susceptibility;
ischemic stroke;
cyp11b1 gene ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2020.00410
Abstract: Objective: 11β-hydroxylase deficiency (11βOHD) is a rare autosomal recessive disorder caused by mutations in the CYP11B1 gene. It is characterized by virilization, hypertension, and significant final height impairment. In this study, we aim to investigate…
read more here.
Keywords:
clinical molecular;
analysis;
hydroxylase deficiency;
cyp11b1 gene ... See more keywords